Johnson & Johnson has filed two applications to expand the use of its drug Tremfya for treating pediatric patients with psoriasis and juvenile psoriatic arthritis.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay
Johnson & Johnson has filed two applications to expand the use of its drug Tremfya for treating pediatric patients with psoriasis and juvenile psoriatic arthritis.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay